{"id":27455,"date":"2022-05-02T14:54:31","date_gmt":"2022-05-02T12:54:31","guid":{"rendered":"https:\/\/irb.usi.ch\/?p=27455"},"modified":"2022-05-03T16:22:11","modified_gmt":"2022-05-03T14:22:11","slug":"differentiation-of-effector-gamma-delta-t-cells-and-application-in-cancer-immunotherapy","status":"publish","type":"post","link":"https:\/\/irb.usi.ch\/it\/events\/differentiation-of-effector-gamma-delta-t-cells-and-application-in-cancer-immunotherapy\/","title":{"rendered":"Differentiation of effector gamma-delta T cells and application in cancer immunotherapy"},"content":{"rendered":"<div class=\"elementor-element elementor-element-5cfcb7d elementor-widget elementor-widget-heading\" data-id=\"5cfcb7d\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n<div class=\"elementor-widget-container\">From: Instituto de Medicina Molecular, University of Lisbon (P)<\/div>\n<\/div>\n<div class=\"elementor-element elementor-element-3c55bce9 elementor-widget elementor-widget-theme-post-content\" data-id=\"3c55bce9\" data-element_type=\"widget\" data-widget_type=\"theme-post-content.default\">\n<div class=\"elementor-widget-container\">\n<p>PhD Program Coordinator:\u00a0<a href=\"https:\/\/irb.usi.ch\/irb-people\/monticelli-silvia\/\">Silvia Monticelli<\/a><\/p>\n<p>Date: 29.04.2022 12:00 pm<\/p>\n<p>Speakers: Prof. Dr. Bruno Silva-Santos<\/p>\n<p>Hybrid Conference<\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>From: Instituto de Medicina Molecular, University of Lisbon (P) PhD Program Coordinator:\u00a0Silvia Monticelli Date: 29.04.2022 12:00 pm Speakers: Prof. Dr. Bruno Silva-Santos Hybrid Conference<\/p>\n","protected":false},"author":136,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[12],"tags":[],"class_list":["post-27455","post","type-post","status-publish","format-standard","hentry","category-events"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Differentiation of effector gamma-delta T cells and application in cancer immunotherapy - IRB USI<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irb.usi.ch\/it\/events\/differentiation-of-effector-gamma-delta-t-cells-and-application-in-cancer-immunotherapy\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Differentiation of effector gamma-delta T cells and application in cancer immunotherapy - IRB USI\" \/>\n<meta property=\"og:description\" content=\"From: Instituto de Medicina Molecular, University of Lisbon (P) PhD Program Coordinator:\u00a0Silvia Monticelli Date: 29.04.2022 12:00 pm Speakers: Prof. Dr. Bruno Silva-Santos Hybrid Conference\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irb.usi.ch\/it\/events\/differentiation-of-effector-gamma-delta-t-cells-and-application-in-cancer-immunotherapy\/\" \/>\n<meta property=\"og:site_name\" content=\"IRB USI\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-02T12:54:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-05-03T14:22:11+00:00\" \/>\n<meta name=\"author\" content=\"Andrea Nava\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"Andrea Nava\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/irb.usi.ch\\\/it\\\/events\\\/differentiation-of-effector-gamma-delta-t-cells-and-application-in-cancer-immunotherapy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/irb.usi.ch\\\/it\\\/events\\\/differentiation-of-effector-gamma-delta-t-cells-and-application-in-cancer-immunotherapy\\\/\"},\"author\":{\"name\":\"Andrea Nava\",\"@id\":\"https:\\\/\\\/irb.usi.ch\\\/it\\\/#\\\/schema\\\/person\\\/01bacbaaa75ea23cfc275a8fb0e0ab94\"},\"headline\":\"Differentiation of effector gamma-delta T cells and application in cancer immunotherapy\",\"datePublished\":\"2022-05-02T12:54:31+00:00\",\"dateModified\":\"2022-05-03T14:22:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/irb.usi.ch\\\/it\\\/events\\\/differentiation-of-effector-gamma-delta-t-cells-and-application-in-cancer-immunotherapy\\\/\"},\"wordCount\":34,\"publisher\":{\"@id\":\"https:\\\/\\\/irb.usi.ch\\\/it\\\/#organization\"},\"articleSection\":[\"Events\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/irb.usi.ch\\\/it\\\/events\\\/differentiation-of-effector-gamma-delta-t-cells-and-application-in-cancer-immunotherapy\\\/\",\"url\":\"https:\\\/\\\/irb.usi.ch\\\/it\\\/events\\\/differentiation-of-effector-gamma-delta-t-cells-and-application-in-cancer-immunotherapy\\\/\",\"name\":\"Differentiation of effector gamma-delta T cells and application in cancer immunotherapy - IRB USI\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/irb.usi.ch\\\/it\\\/#website\"},\"datePublished\":\"2022-05-02T12:54:31+00:00\",\"dateModified\":\"2022-05-03T14:22:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/irb.usi.ch\\\/it\\\/events\\\/differentiation-of-effector-gamma-delta-t-cells-and-application-in-cancer-immunotherapy\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/irb.usi.ch\\\/it\\\/events\\\/differentiation-of-effector-gamma-delta-t-cells-and-application-in-cancer-immunotherapy\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/irb.usi.ch\\\/it\\\/events\\\/differentiation-of-effector-gamma-delta-t-cells-and-application-in-cancer-immunotherapy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/irb.usi.ch\\\/it\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Events\",\"item\":\"https:\\\/\\\/irb.usi.ch\\\/.\\\/events\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Differentiation of effector gamma-delta T cells and application in cancer immunotherapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/irb.usi.ch\\\/it\\\/#website\",\"url\":\"https:\\\/\\\/irb.usi.ch\\\/it\\\/\",\"name\":\"IRB USI\",\"description\":\"Institute for Research in Biomedicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/irb.usi.ch\\\/it\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/irb.usi.ch\\\/it\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/irb.usi.ch\\\/it\\\/#organization\",\"name\":\"IRB USI\",\"url\":\"https:\\\/\\\/irb.usi.ch\\\/it\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/irb.usi.ch\\\/it\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/irb.usi.ch\\\/images\\\/IRB-Usi.svg\",\"contentUrl\":\"https:\\\/\\\/irb.usi.ch\\\/images\\\/IRB-Usi.svg\",\"width\":98,\"height\":43,\"caption\":\"IRB USI\"},\"image\":{\"@id\":\"https:\\\/\\\/irb.usi.ch\\\/it\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/irb.usi.ch\\\/it\\\/#\\\/schema\\\/person\\\/01bacbaaa75ea23cfc275a8fb0e0ab94\",\"name\":\"Andrea Nava\",\"sameAs\":[\"https:\\\/\\\/irb.usi.ch\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Differentiation of effector gamma-delta T cells and application in cancer immunotherapy - IRB USI","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irb.usi.ch\/it\/events\/differentiation-of-effector-gamma-delta-t-cells-and-application-in-cancer-immunotherapy\/","og_locale":"it_IT","og_type":"article","og_title":"Differentiation of effector gamma-delta T cells and application in cancer immunotherapy - IRB USI","og_description":"From: Instituto de Medicina Molecular, University of Lisbon (P) PhD Program Coordinator:\u00a0Silvia Monticelli Date: 29.04.2022 12:00 pm Speakers: Prof. Dr. Bruno Silva-Santos Hybrid Conference","og_url":"https:\/\/irb.usi.ch\/it\/events\/differentiation-of-effector-gamma-delta-t-cells-and-application-in-cancer-immunotherapy\/","og_site_name":"IRB USI","article_published_time":"2022-05-02T12:54:31+00:00","article_modified_time":"2022-05-03T14:22:11+00:00","author":"Andrea Nava","twitter_card":"summary_large_image","twitter_misc":{"Scritto da":"Andrea Nava","Tempo di lettura stimato":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/irb.usi.ch\/it\/events\/differentiation-of-effector-gamma-delta-t-cells-and-application-in-cancer-immunotherapy\/#article","isPartOf":{"@id":"https:\/\/irb.usi.ch\/it\/events\/differentiation-of-effector-gamma-delta-t-cells-and-application-in-cancer-immunotherapy\/"},"author":{"name":"Andrea Nava","@id":"https:\/\/irb.usi.ch\/it\/#\/schema\/person\/01bacbaaa75ea23cfc275a8fb0e0ab94"},"headline":"Differentiation of effector gamma-delta T cells and application in cancer immunotherapy","datePublished":"2022-05-02T12:54:31+00:00","dateModified":"2022-05-03T14:22:11+00:00","mainEntityOfPage":{"@id":"https:\/\/irb.usi.ch\/it\/events\/differentiation-of-effector-gamma-delta-t-cells-and-application-in-cancer-immunotherapy\/"},"wordCount":34,"publisher":{"@id":"https:\/\/irb.usi.ch\/it\/#organization"},"articleSection":["Events"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/irb.usi.ch\/it\/events\/differentiation-of-effector-gamma-delta-t-cells-and-application-in-cancer-immunotherapy\/","url":"https:\/\/irb.usi.ch\/it\/events\/differentiation-of-effector-gamma-delta-t-cells-and-application-in-cancer-immunotherapy\/","name":"Differentiation of effector gamma-delta T cells and application in cancer immunotherapy - IRB USI","isPartOf":{"@id":"https:\/\/irb.usi.ch\/it\/#website"},"datePublished":"2022-05-02T12:54:31+00:00","dateModified":"2022-05-03T14:22:11+00:00","breadcrumb":{"@id":"https:\/\/irb.usi.ch\/it\/events\/differentiation-of-effector-gamma-delta-t-cells-and-application-in-cancer-immunotherapy\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irb.usi.ch\/it\/events\/differentiation-of-effector-gamma-delta-t-cells-and-application-in-cancer-immunotherapy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irb.usi.ch\/it\/events\/differentiation-of-effector-gamma-delta-t-cells-and-application-in-cancer-immunotherapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irb.usi.ch\/it\/"},{"@type":"ListItem","position":2,"name":"Events","item":"https:\/\/irb.usi.ch\/.\/events\/"},{"@type":"ListItem","position":3,"name":"Differentiation of effector gamma-delta T cells and application in cancer immunotherapy"}]},{"@type":"WebSite","@id":"https:\/\/irb.usi.ch\/it\/#website","url":"https:\/\/irb.usi.ch\/it\/","name":"IRB USI","description":"Institute for Research in Biomedicine","publisher":{"@id":"https:\/\/irb.usi.ch\/it\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irb.usi.ch\/it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/irb.usi.ch\/it\/#organization","name":"IRB USI","url":"https:\/\/irb.usi.ch\/it\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/irb.usi.ch\/it\/#\/schema\/logo\/image\/","url":"https:\/\/irb.usi.ch\/images\/IRB-Usi.svg","contentUrl":"https:\/\/irb.usi.ch\/images\/IRB-Usi.svg","width":98,"height":43,"caption":"IRB USI"},"image":{"@id":"https:\/\/irb.usi.ch\/it\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/irb.usi.ch\/it\/#\/schema\/person\/01bacbaaa75ea23cfc275a8fb0e0ab94","name":"Andrea Nava","sameAs":["https:\/\/irb.usi.ch"]}]}},"_links":{"self":[{"href":"https:\/\/irb.usi.ch\/it\/wp-json\/wp\/v2\/posts\/27455","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irb.usi.ch\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/irb.usi.ch\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/irb.usi.ch\/it\/wp-json\/wp\/v2\/users\/136"}],"replies":[{"embeddable":true,"href":"https:\/\/irb.usi.ch\/it\/wp-json\/wp\/v2\/comments?post=27455"}],"version-history":[{"count":3,"href":"https:\/\/irb.usi.ch\/it\/wp-json\/wp\/v2\/posts\/27455\/revisions"}],"predecessor-version":[{"id":27522,"href":"https:\/\/irb.usi.ch\/it\/wp-json\/wp\/v2\/posts\/27455\/revisions\/27522"}],"wp:attachment":[{"href":"https:\/\/irb.usi.ch\/it\/wp-json\/wp\/v2\/media?parent=27455"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/irb.usi.ch\/it\/wp-json\/wp\/v2\/categories?post=27455"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/irb.usi.ch\/it\/wp-json\/wp\/v2\/tags?post=27455"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}